TGT
49
5
SO
55
-2
NOC
56
2
QCOM
59
-4
UA
51
-6
GM
72
3
CNX
80
4
BMY
64
21
AVB
65
-2
CAT
64
2
MSFT
51
-4
MMC
61
-3
NUE
62
-2
BAC
57
3
PNR
75
4
DOV
71
2
NRG
52
-5
ADI
49
-2
PPL
59
2
PEG
62
4
TGT
49
5
SO
55
-2
NOC
56
2
QCOM
59
-4
UA
51
-6
GM
72
3
CNX
80
4
BMY
64
21
AVB
65
-2
CAT
64
2
MSFT
51
-4
MMC
61
-3
NUE
62
-2
BAC
57
3
PNR
75
4
DOV
71
2
NRG
52
-5
ADI
49
-2
PPL
59
2
PEG
62
4
Financhill
Back

C4 Therapeutics Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
20

CCCC
C4 Therapeutics

Last Price:
5.51
Seasonality Move:
60.44%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

C4 Therapeutics Price Quote

$5.51
-0.38 (-6.45%)
(Updated: November 12, 2024 at 5:55 PM ET)

C4 Therapeutics Key Stats

Sell
20
C4 Therapeutics (CCCC) is a Sell
Day range:
$5.76 - $6.20
52-week range:
$1.06 - $11.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.29
P/B ratio:
1.71%
Volume:
827.2K
Avg. volume:
814.7K
1-year change:
242.44%
Market cap:
$415.8M
Revenue:
$20.8M
EPS:
$-1.7

How Much Does C4 Therapeutics Make?

Is C4 Therapeutics Growing As A Company?

  • What Is C4 Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is C4 Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

C4 Therapeutics Stock Price Performance

  • Did C4 Therapeutics Stock Go Up Last Month?
    C4 Therapeutics share price went up by 7.88% last month
  • Did CCCC's Share Price Rise Over The Last Year?
    CCCC share price rose by 242.44% over the past 1 year

What Is C4 Therapeutics 52-Week High & Low?

C4 Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy C4 Therapeutics?

  • How Much Debt Does C4 Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does C4 Therapeutics Have?
    Cash and short term investments quarterly total is $255.6M
  • What Is C4 Therapeutics’s Book Value Per Share?
    Book value per share is 3.44

Is C4 Therapeutics Cash Flow Positive?

  • What Is CCCC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.2M
  • What Is C4 Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $102.9M
  • What Is C4 Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$33M

C4 Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CCCC return on invested capital is -43.59%
  • What Is C4 Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -28.28%
  • What Is CCCC Return On Equity?
    ROE is a measure of profitability and is -43.59%

C4 Therapeutics Earnings Date & Stock Price

C4 Therapeutics Competitors

  • Who Are C4 Therapeutics's Competitors?
    Below is a list of companies who compete with C4 Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Biogen Inc (BIIB)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)

C4 Therapeutics Dividend Yield

C4 Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.14%
Revenue: 38.75% 233.96%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 15.00
Upside from Last Price: 154.67%

Major Shareholders

  • How many CCCC shares are owned by institutional investors?
    78.9M CCCC shares are owned by institutional investors
  • How many CCCC shares are owned by insiders?
    1.5M CCCC shares are owned by insiders